289 related articles for article (PubMed ID: 32060274)
21. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068
[TBL] [Abstract][Full Text] [Related]
22. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
Ogasawara M; Rosenberg SA
Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
[TBL] [Abstract][Full Text] [Related]
23. Immunoproteasome-specific inhibitors and their application.
Basler M; Groettrup M
Methods Mol Biol; 2012; 832():391-401. PubMed ID: 22350900
[TBL] [Abstract][Full Text] [Related]
24. Anti-viral immune response in the lung and thymus: Molecular characterization and expression analysis of immunoproteasome subunits LMP2, LMP7 and MECL-1 in pigs.
Liu Q; Hu W; Zhang YL; Hu SP; Zhang Z; He XJ; Cai XH
Biochem Biophys Res Commun; 2018 Aug; 502(4):472-478. PubMed ID: 29856997
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer.
Shoji T; Kikuchi E; Kikuchi J; Takashima Y; Furuta M; Takahashi H; Tsuji K; Maeda M; Kinoshita I; Dosaka-Akita H; Sakakibara-Konishi J; Konno S
Cancer Chemother Pharmacol; 2020 May; 85(5):843-853. PubMed ID: 32232513
[TBL] [Abstract][Full Text] [Related]
26. Immunoproteasomes edit tumors, which then escapes immune recognition.
Joyce S
Eur J Immunol; 2015 Dec; 45(12):3241-5. PubMed ID: 26527367
[TBL] [Abstract][Full Text] [Related]
27. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.
Sun Y; Sijts AJ; Song M; Janek K; Nussbaum AK; Kral S; Schirle M; Stevanovic S; Paschen A; Schild H; Kloetzel PM; Schadendorf D
Cancer Res; 2002 May; 62(10):2875-82. PubMed ID: 12019167
[TBL] [Abstract][Full Text] [Related]
28. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.
Bhattarai S; Ghannam K; Krause S; Benveniste O; Marg A; de Bruin G; Xin BT; Overkleeft HS; Spuler S; Stenzel W; Feist E
J Autoimmun; 2016 Dec; 75():118-129. PubMed ID: 27522114
[TBL] [Abstract][Full Text] [Related]
29. Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors.
Budczies J; Bockmayr M; Klauschen F; Endris V; Fröhling S; Schirmacher P; Denkert C; Stenzinger A
Genes Chromosomes Cancer; 2017 Aug; 56(8):651-659. PubMed ID: 28466543
[TBL] [Abstract][Full Text] [Related]
30. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
[TBL] [Abstract][Full Text] [Related]
31. Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies.
Bandoh N; Ogino T; Cho HS; Hur SY; Shen J; Wang X; Kato S; Miyokawa N; Harabuchi Y; Ferrone S
Tissue Antigens; 2005 Sep; 66(3):185-94. PubMed ID: 16101829
[TBL] [Abstract][Full Text] [Related]
32. Expression of immunoproteasome subunits in the porcine lung: Alterations during normal and inflammatory conditions.
Liu Q; Zhang YL; Hu SP; Ma ZL; Gao SL; Sun B; Xiao F; Zhang Z; Cai XH; He XJ
Vet Microbiol; 2017 Oct; 210():134-141. PubMed ID: 29103682
[TBL] [Abstract][Full Text] [Related]
33. Pan-cancer analysis of the prognostic and immunological role of PSMB8.
Chen D; Jin C; Dong X; Wen J; Xia E; Wang Q; Wang O
Sci Rep; 2021 Oct; 11(1):20492. PubMed ID: 34650125
[TBL] [Abstract][Full Text] [Related]
34. Immunoproteasome Subunits Are Required for CD8
Guimarães G; Gomes MTR; Campos PC; Marinho FV; de Assis NRG; Silveira TN; Oliveira SC
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263103
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers.
Geoffroy K; Araripe Saraiva B; Viens M; Béland D; Bourgeois-Daigneault MC
Sci Rep; 2023 Feb; 13(1):2129. PubMed ID: 36746983
[TBL] [Abstract][Full Text] [Related]
36. ER-aminopeptidase 1 determines the processing and presentation of an immunotherapy-relevant melanoma epitope.
Textoris-Taube K; Cammann C; Henklein P; Topfstedt E; Ebstein F; Henze S; Liepe J; Zhao F; Schadendorf D; Dahlmann B; Uckert W; Paschen A; Mishto M; Seifert U
Eur J Immunol; 2020 Feb; 50(2):270-283. PubMed ID: 31729751
[TBL] [Abstract][Full Text] [Related]
37. Proteasome function in antigen presentation: immunoproteasome complexes, Peptide production, and interactions with viral proteins.
Rivett AJ; Hearn AR
Curr Protein Pept Sci; 2004 Jun; 5(3):153-61. PubMed ID: 15180520
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of the proteasome subunits, transporter, and antigen presentation in hepatocellular carcinoma, and their restoration by interferon-gamma.
Matsui M; Machida S; Itani-Yohda T; Akatsuka T
J Gastroenterol Hepatol; 2002 Aug; 17(8):897-907. PubMed ID: 12164966
[TBL] [Abstract][Full Text] [Related]
39. Immunoproteasome deficiency modifies the alternative pathway of NFκB signaling.
Maldonado M; Kapphahn RJ; Terluk MR; Heuss ND; Yuan C; Gregerson DS; Ferrington DA
PLoS One; 2013; 8(2):e56187. PubMed ID: 23457524
[TBL] [Abstract][Full Text] [Related]
40. Degradation of heme oxygenase-1 by the immunoproteasome in astrocytes: A potential interferon-γ-dependent mechanism contributing to HIV neuropathogenesis.
Kovacsics CE; Gill AJ; Ambegaokar SS; Gelman BB; Kolson DL
Glia; 2017 Aug; 65(8):1264-1277. PubMed ID: 28543773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
